🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
4.080
-0.910 (-18.24%)
At close: Nov 18, 2026, 4:00 PM EST
4.150
+0.070 (1.72%)
After-hours: Nov 18, 2026, 4:15 PM EST

aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $10.40 million. The enterprise value is -$27.43 million.

Market Cap10.40M
Enterprise Value -27.43M

Important Dates

The last earnings date was Thursday, November 5, 2026, after market close.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

aTyr Pharma has 2.55 million shares outstanding. The number of shares has increased by 10.03% in one year.

Current Share Class 2.55M
Shares Outstanding 2.55M
Shares Change (YoY) +10.03%
Shares Change (QoQ) +0.20%
Owned by Insiders (%) 0.34%
Owned by Institutions (%) 22.71%
Float 2.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.37
P/TBV Ratio 0.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.32.

Current Ratio 3.05
Quick Ratio 3.00
Debt / Equity 0.32
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -93.68% and return on invested capital (ROIC) is -50.97%.

Return on Equity (ROE) -93.68%
Return on Assets (ROA) -41.98%
Return on Invested Capital (ROIC) -50.97%
Return on Capital Employed (ROCE) -128.98%
Weighted Average Cost of Capital (WACC) 5.06%
Revenue Per Employee n/a
Profits Per Employee -$888,733
Employee Count60
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.64% in the last 52 weeks. The beta is 1.05, so aTyr Pharma's price volatility has been similar to the market average.

Beta (5Y) 1.05
52-Week Price Change -84.64%
50-Day Moving Average 9.46
200-Day Moving Average 22.58
Relative Strength Index (RSI) 27.88
Average Volume (20 Days) 116,682

Short Selling Information

The latest short interest is 293,448, so 11.51% of the outstanding shares have been sold short.

Short Interest 293,448
Short Previous Month 10.27M
Short % of Shares Out 11.51%
Short % of Float 11.55%
Short Ratio (days to cover) 4.41

Income Statement

Revenue n/a
Gross Profit -35.40M
Operating Income -55.91M
Pretax Income -53.32M
Net Income -53.32M
EBITDA -55.24M
EBIT -55.91M
Earnings Per Share (EPS) -$21.74
Full Income Statement

Balance Sheet

The company has $48.75 million in cash and $10.92 million in debt, with a net cash position of $37.83 million or $14.84 per share.

Cash & Cash Equivalents 48.75M
Total Debt 10.92M
Net Cash 37.83M
Net Cash Per Share $14.84
Equity (Book Value) 33.79M
Book Value Per Share 13.53
Working Capital 33.69M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.58 million and capital expenditures -$287,000, giving a free cash flow of -$43.86 million.

Operating Cash Flow -43.58M
Capital Expenditures -287,000
Depreciation & Amortization 667,000
Net Borrowing -540,000
Free Cash Flow -43.86M
FCF Per Share -$17.21
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -10.03%
Shareholder Yield -10.03%
Earnings Yield -532.84%
FCF Yield -393.28%

Analyst Forecast

The average price target for aTyr Pharma is $45.17, which is 1,007.11% higher than the current price. The consensus rating is "Hold".

Price Target $45.17
Price Target Difference 1,007.11%
Analyst Consensus Hold
Analyst Count 9
Revenue Growth Forecast (3Y) 125.28%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 29, 2026. It was a reverse split with a ratio of 1:40.

Last Split Date Oct 29, 2026
Split Type Reverse
Split Ratio 1:40

Scores

aTyr Pharma has an Altman Z-Score of -15.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.94
Piotroski F-Score 1